The AstraZeneca PLC ADR /zigman2/quotes/200304487/composite AZN +1.71% rose 1.46% to $60.35 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.47% rising 0.10% to 34,798.00 and the NASDAQ Composite Index /zigman2/quotes/210598365/realtime COMP +0.65% falling 0.03% to 15,047.70. This was the ADR's second consecutive day of gains. AstraZeneca PLC ADR closed $0.58 short of its 52-week high ($60.93), which the company achieved on July 12th.
The ADR outperformed some of its competitors Friday, as AbbVie Inc. /zigman2/quotes/202428675/composite ABBV +0.18% fell 0.27% to $107.07, Amgen Inc. /zigman2/quotes/209157011/composite AMGN +1.30% fell 0.67% to $213.61, and Gilead Sciences Inc. /zigman2/quotes/210293917/composite GILD +1.56% fell 0.70% to $71.19. Trading volume (10.1 M) remained 255,031 below its 50-day average volume of 10.3 M.